• $200K Saved With First-Line Docetaxel for Prostate Cancer

    13 days ago - By Medscape

    For the first time, there is a cost-effectiveness study on two systemic drugs used in the treatment of newly diagnosed metastatic prostate cancer.
    Medscape Medical News
    Read more ...